Sinovac Biotech SVA
NASDAQ SVA
$6.47 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

Sinovac Biotech (SVA) Preferred Shares (2019 - 2020)

Updated

Sinovac Biotech's Preferred Shares was $15,000 in Q4 2020, unchanged from $15,000 a year earlier.

Analysis

Sinovac Biotech (SVA) Preferred Shares (2019 - 2020) Analysis & Trends

  • In earlier years, Preferred Shares was $15,000 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Sinovac Biotech 464.94 Mn -35.05 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 15,000.00
Dec 31, 2019 15,000.00
API Access

Sinovac Biotech Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=SVA&period=max&api_key=YOUR_API_KEY